Hexaell Biotech Co., Ltd.
PrivateLast Round
Series B++
Apr 25, 2026
Total Funding Raised
$52.2M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Hexaell Biotech Co., Ltd. is a biotechnology company that develops therapies for severe liver diseases using cell transdifferentiation technology.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Clinical Trials, Drug Discovery
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Hexaell Biotech Co., Ltd. Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Hexaell Biotech Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B++ | Apr 25, 2026 | ||||
| Series B | Feb 11, 2025 | ||||
| Series A | Dec 24, 2018 |
Hexaell Biotech Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Fuhui Venture Capital | Series B++ |
| Shanghai Healthcare Capital | Series B |
| Shum Yip Capital | Series B++ |
| Zhongshan Cuiheng Group Co., Ltd. | Series B++ |
| Guangdong Yueke Financial Group | Series B++ |
| Hyfinity Investments | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 25, 2026
$14M round with participation from Shum Yip Capital and Fuho Capital.
- Feb 11, 2025
$31M round led by Shanghai Biomedical Industrial Equity Investment Fund
Hexaell Biotech Co., Ltd. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Hexaell Biotech Co., Ltd.'s valuation, stock price, and market status.